Cerus Corp Share Price Today: Live Updates & Key Insights
Cerus Corp share price today is $1.7, up -5.03%. The stock opened at $1.73 against the previous close of $1.79, with an intraday high of $1.74 and low of $1.62.
Cerus Corp Share Price Chart
Cerus Corp Share Price Performance
Cerus Corp Institutional Holdings
Cerus Corp Market Status
Cerus Corp Fundamentals
Market Cap 343.99 M
PB Ratio 5.3561
PE Ratio 0.0
Enterprise Value 358.05 M
Total Assets 221.86 M
Volume 3232937
Cerus Corp Company Financials
About Cerus Corp & investment objective
Company Information Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells intended for transfusion; INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma and cryoprecipitate reduced; and INTERCEPT Illuminator, an LED-based device for blood component treatment. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was formerly known as CERUS TECHNOLOGIES INC and changed its name to Cerus Corporation in July 1996. The company was incorporated in 1991 and is headquartered in Concord, California.
Organisation Medical Devices
Employees 261
Industry Medical Devices
CEO Mr. William M. Greenman
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
